BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2017
View Archived Issues
EMA grants orphan drug designation for DCC-2618 as treatment of gastrointestinal stromal tumors
Read More
MLR-1019 ameliorates dyskinesia and neuron bursting in Parkinsonian rats
Read More
FDA accepts IND for CTLA-4 Probody therapeutic from BMS and CytomX
Read More
Axsome Therapeutics announces new product candidate for treatment of migraine
Read More
Vedanta in new and expanded collaborations to support microbiome work in cancer immunotherapy
Read More
Nippon Chemiphar completes phase I trial of NC-2500 and preclinical studies with NC-2700
Read More
Idera Pharmaceuticals' IMO-2125 awarded FDA fast track designation
Read More
FDA gives orphan drug designation to Amphivena Therapeutics' AMV-564
Read More
Melinta Therapeutics to acquire infectious disease business from The Medicines Company
Read More
Aptinyx tests PTSD candidate NYX-783 in animal models
Read More
Zogenix begins phase III study of ZX-008 in Lennox-Gastaut syndrome
Read More
Researchers develop mouse model of coronary collateral vessel growth
Read More
Peptide anti-PCSK9 vaccine shows promise for treating dyslipidemia
Read More
EMA gives orphan drug designation to ProQR Therapeutics' QR-313
Read More
HanAll initiates phase II trial of HL-036 to treat signs and symptoms of dry eye
Read More
ID Pharma submits CTN in Japan for DiscGenics' IDCT-001 clinical trial
Read More
Cambridge Enterprise, Sydney Children's Hospitals Network design viral vectors encoding factor I
Read More
Idorsia Pharmaceuticals patents novel antibacterials
Read More
Lilly identifies novel beta-secretase 1 inhibitors
Read More
Researchers present SUVN-1603054, a novel antipsychotic for treating schizophrenia
Read More
Novel soluble guanylate cyclase activators discovered at Merck & Co.
Read More
Istituto Europeo di Oncologia Srl synthesizes new lysine-specific demethylase 4C inhiibitors
Read More
First pediatric patient dosed in phase I/II study of AEB-1102 in arginase 1 deficiency
Read More
Regeneron and Decibel collaborate to develop therapeutics for hearing loss
Read More
Pharnext gives update on phase III PLEO-CMT study
Read More
Sanofi updates information on Dengvaxia
Read More
TherapeuticsMD resubmits NDA for TX-004-HR for dyspareunia
Read More
ViiV initiates phase III study of long-acting cabotegravir for prevention of HIV infection in women
Read More
AstraZeneca studies AZD-5718 in patients with coronary artery disease
Read More